Can uterine fibroids cause polycythemia in a woman?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Uterine Fibroids Cause Polycythemia?

Yes, uterine fibroids can cause polycythemia, though this is an extremely rare complication, particularly with large fibroids in postmenopausal women. 1

Mechanism of Fibroid-Associated Polycythemia

The development of polycythemia from uterine fibroids occurs through three postulated mechanisms 1:

  • Intratumoral hypoxia and shunting: Large fibroids develop complex vascular networks that may create hypoxic conditions within the tumor, triggering compensatory erythropoietin production 1

  • Ureteral compression: Massive fibroids can compress the ureters, leading to inappropriate excessive erythropoietin production by the kidneys in response to perceived renal hypoxia 1

  • Ectopic erythropoietin production: The fibroid tumor itself may directly produce erythropoietin 1

Clinical Context and Rarity

This is an exceptionally uncommon presentation that contrasts sharply with the typical hematologic manifestation of fibroids:

  • The overwhelming majority of symptomatic fibroids cause anemia, not polycythemia, with iron deficiency anemia affecting approximately 10% of women in the United States due to heavy menstrual bleeding (≥80 mL/month) 2

  • Polycythemia associated with fibroids has been documented primarily in postmenopausal women with very large tumors 1

  • The case literature describes fibroids that increased in size over time in postmenopausal women, which itself raises concern for malignancy until proven otherwise 1

Critical Clinical Pitfall

When encountering a postmenopausal woman with an enlarging fibroid and polycythemia, leiomyosarcoma must be excluded. 3, 1

  • Postmenopausal fibroid growth or persistent abnormal bleeding significantly increases suspicion for malignancy 3

  • Leiomyosarcomas comprise only 0.1% of all uterine tumors, but incidence increases to 1.7% in women undergoing hysterectomy for fibroids in their seventh decade 3

  • Definitive histopathologic examination is essential to confirm benign leiomyoma versus sarcomatous transformation 1

Management Approach

For a woman presenting with polycythemia and uterine fibroids 1:

  • Treat the polycythemia symptomatically with therapeutic phlebotomy (venesection) while evaluating the fibroid 1

  • Perform definitive surgical management with total abdominal hysterectomy and bilateral salpingo-oophorectomy, particularly in postmenopausal women 1

  • Obtain complete histopathologic examination of all specimens to exclude malignancy 3, 1

  • Resolution of polycythemia typically occurs after removal of the causative fibroid 1

References

Guideline

Uterine Fibroids and Iron Deficiency Anemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Uterine Fibroids Characteristics and Clinical Implications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What are the initial medical management recommendations for a postmenopausal woman or a woman of reproductive age with uterine fibroids?
What are the treatment options for a patient with uterine fibroids experiencing heavy menstrual bleeding and pelvic pain?
What are the complications and management options for a premenopausal woman in her 30s or 40s with a huge uterine fibroid and symptoms of heavy menstrual bleeding, pelvic pressure, or pain?
How often should the size of a uterine fibroid be checked?
What are the treatment options for a female patient, likely between 30 and 50 years old, with fibroids at the right apex, as indicated by an X-ray result?
Can lithium orotate cause stomach pain in patients, particularly those with a history of gastrointestinal disorders?
What considerations should be taken when switching a patient of unknown age with bipolar depression from Caplyta (lumateperone) to Symbyax (olanzapine/fluoxetine)?
What is the best management plan for a 72-year-old female patient with a history of Diabetes Mellitus (DM), Hypertension (HPT), and Liver Cirrhosis (Child Pugh B) due to Non-Alcoholic Fatty Liver Disease (NAFLD), presenting with septic shock, hypotensive episodes, and anemia, with a recent history of infected wound over the left hip, symptomatic ascites, and acute kidney injury (AKI) secondary to sepsis and hepatorenal syndrome?
What are the next steps in managing a patient with elevated liver enzymes, specifically an AST of 99?
What is the recommended dosage and administration schedule for the Gardasil (Human Papillomavirus (HPV) vaccine) vaccine?
What are the differential diagnoses for a pediatric patient presenting with motor axonal affection in the right median and ulnar nerves?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.